Amgen (AMGN)
(Delayed Data from NSDQ)
$308.45 USD
-1.70 (-0.55%)
Updated May 13, 2024 04:00 PM ET
After-Market: $308.99 +0.54 (0.18%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (84 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.12 | 1.35 | 9.99 |
Current Quarter Estimate | 4.87 | 7.43 | 57.00 |
Year Ago Quarter Estimate | 5.00 | 0.12 | 52.54 |
Next Quarter Estimate | 5.15 | 7.81 | 61.00 |
Next Year Estimate | 20.59 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 4.34 | 12.90 | 15.67 |
Next Year | 5.81 | 8.50 | 9.31 |
Last 5 Years | 6.00 | 1.00 | 8.10 |
Next 5 Years | 5.70 | 20.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 16.65 | -2.18 |
Price/Book (MRQ) | 33.13 | 2.14 |
Price/Cash Flow (MRFY) | 11.77 | 15.07 |
Dividend Yield | 2.90% | 0.00% |
Net Profit Margin (TTM) | 12.74% | -15.18% |
Return on Equity (TTM) | 156.21% | -19.32% |
Debt to Equity (MRQ) | 11.96 | 1.82 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.